Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Nissen

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2020
Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence studyJ F B Schwensen, V W Nielsen, C V Nissen, et al.
Medical Mycology|July 2, 2015
Discovery of a sexual stage in Trichophyton onychocola, a presumed geophilic dermatophyte isolated from toenails of patients with a history of T. rubrum onychomycosisVit Hubka, Christoffer V Nissen, Rasmus Hare Jensen, et al.
Lasers in Surgery and Medicine|October 14, 2022
Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosisG L Grove, K Togsverd-Bo, J F B Schwensen, et al.
Rheumatology (Oxford, England)|December 16, 2020
Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort studyChristine Ballegaard, Marie Skougaard, Jørgen Guldberg-Møller, et al.
Acta Dermato-Venereologica|October 13, 2021
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort StudyChristopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2023
A value-based healthcare model for initiating and switching psoriasis therapies-Results from the prospective multicentre IMPROVE studyV W Nielsen, C B Johansen, T Todberg, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2022
Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide studyN Loft, A Egeberg, M K Rasmussen, et al.
The Lancet Regional Health. Europe|July 19, 2023
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)Mette Gyldenløve, Howraman Meteran, Jennifer A Sørensen, et al.
International Journal of Cardiology. Heart & Vasculature|November 24, 2025
High-sensitivity C-reactive protein is associated with altered cardiac structure and function in psoriasis: The PSOCADIA studyMaria Dons, Morten Sengeløv, Kristoffer Grundtvig Skaarup, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2020
Effectiveness and safety of guselkumab in 50 patients with moderate to severe plaque psoriasis who had previously been treated with other biologics: a retrospective real-world evidence studyJ F B Schwensen, V W Nielsen, C V Nissen, et al.
Medical Mycology|July 2, 2015
Discovery of a sexual stage in Trichophyton onychocola, a presumed geophilic dermatophyte isolated from toenails of patients with a history of T. rubrum onychomycosisVit Hubka, Christoffer V Nissen, Rasmus Hare Jensen, et al.
Lasers in Surgery and Medicine|October 14, 2022
Impact of microwave thermolysis energy levels on patient-reported outcomes for axillary hyperhidrosis and osmidrosisG L Grove, K Togsverd-Bo, J F B Schwensen, et al.
Rheumatology (Oxford, England)|December 16, 2020
Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort studyChristine Ballegaard, Marie Skougaard, Jørgen Guldberg-Møller, et al.
Acta Dermato-Venereologica|October 13, 2021
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort StudyChristopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2023
A value-based healthcare model for initiating and switching psoriasis therapies-Results from the prospective multicentre IMPROVE studyV W Nielsen, C B Johansen, T Todberg, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 2, 2022
Prevalence and characterization of treatment-refractory psoriasis and super-responders to biologic treatment: a nationwide studyN Loft, A Egeberg, M K Rasmussen, et al.
The Lancet Regional Health. Europe|July 19, 2023
Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis-a randomized controlled trial (PSORRO)Mette Gyldenløve, Howraman Meteran, Jennifer A Sørensen, et al.
International Journal of Cardiology. Heart & Vasculature|November 24, 2025
High-sensitivity C-reactive protein is associated with altered cardiac structure and function in psoriasis: The PSOCADIA studyMaria Dons, Morten Sengeløv, Kristoffer Grundtvig Skaarup, et al.
Pageof 3